Lichun Lu - Search Results

Year	Number of Results
2002	5
2003	2
2004	5
2005	5
2006	5
2007	6
2008	10
2009	10
2010	11
2011	3
2012	3
2013	4
2014	6
2015	8
2016	9
2017	10
2018	17
2019	16
2020	10
2021	21
2022	11
2023	10
2024	6

1

Shp2 Deficiency in Kupffer Cells and Hepatocytes Aggravates Hepatocarcinogenesis by Recruiting Non-Kupffer Macrophages.

Du L, Ji Y, Xin B, Zhang J, Lu LC, Glass CK, Feng GS. Du L, et al. Cell Mol Gastroenterol Hepatol. 2023;15(6):1351-1369. doi: 10.1016/j.jcmgh.2023.02.011. Epub 2023 Feb 23. Cell Mol Gastroenterol Hepatol. 2023. PMID: 36828281 Free PMC article.

2

Cellular Retinoic-Acid Binding Protein 2 in Solid Tumor.

Jiao X, Liu R, Huang J, Lu L, Li Z, Xu L, Li E. Jiao X, et al. Among authors: lu l. Curr Protein Pept Sci. 2020;21(5):507-516. doi: 10.2174/1389203721666200203150721. Curr Protein Pept Sci. 2020. PMID: 32013828 Review.

3

Acoustic Force Elastography Microscopy.

Liu HC, Gaihre B, Kijanka P, Lu L, Urban MW. Liu HC, et al. Among authors: lu l. IEEE Trans Biomed Eng. 2023 Mar;70(3):841-852. doi: 10.1109/TBME.2022.3203435. Epub 2023 Feb 17. IEEE Trans Biomed Eng. 2023. PMID: 36049008 Free PMC article.

4

Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment.

Chen CT, Feng YH, Yen CJ, Chen SC, Lin YT, Lu LC, Hsu CH, Cheng AL, Shao YY. Chen CT, et al. Hepatol Int. 2022 Oct;16(5):1199-1207. doi: 10.1007/s12072-022-10392-x. Epub 2022 Aug 20. Hepatol Int. 2022. PMID: 35986846 Review.

5

Considerations of heterogeneity in clinical trials for hepatocellular carcinoma.

Liu TH, Shao YY, Lu LC, Shen YC, Hsu C, Lin ZZ, Hsu CH, Cheng AL. Liu TH, et al. Expert Rev Gastroenterol Hepatol. 2019 Jul;13(7):615-621. doi: 10.1080/17474124.2019.1621165. Epub 2019 May 27. Expert Rev Gastroenterol Hepatol. 2019. PMID: 31132887 Review.

6

Growth factor interactions in bone regeneration.

Kempen DH, Creemers LB, Alblas J, Lu L, Verbout AJ, Yaszemski MJ, Dhert WJ. Kempen DH, et al. Among authors: lu l. Tissue Eng Part B Rev. 2010 Dec;16(6):551-66. doi: 10.1089/ten.teb.2010.0176. Epub 2010 Nov 1. Tissue Eng Part B Rev. 2010. PMID: 21039299 Review.

7

Tissue engineered constructs: perspectives on clinical translation.

Lu L, Arbit HM, Herrick JL, Segovis SG, Maran A, Yaszemski MJ. Lu L, et al. Ann Biomed Eng. 2015 Mar;43(3):796-804. doi: 10.1007/s10439-015-1280-0. Epub 2015 Feb 25. Ann Biomed Eng. 2015. PMID: 25711151 Free PMC article. Review.

8

2D phosphorene nanosheets, quantum dots, nanoribbons: synthesis and biomedical applications.

Liu X, Gaihre B, George MN, Li Y, Tilton M, Yaszemski MJ, Lu L. Liu X, et al. Among authors: lu l. Biomater Sci. 2021 Apr 21;9(8):2768-2803. doi: 10.1039/d0bm01972k. Epub 2021 Feb 23. Biomater Sci. 2021. PMID: 33620047 Free PMC article. Review.

9

Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the Challenges.

Lu LC, Hsu CH, Hsu C, Cheng AL. Lu LC, et al. Liver Cancer. 2016 Apr;5(2):128-38. doi: 10.1159/000367754. Epub 2016 Mar 17. Liver Cancer. 2016. PMID: 27386431 Free PMC article. Review.

10

3D-printed scaffolds with 2D hetero-nanostructures and immunomodulatory cytokines provide pro-healing microenvironment for enhanced bone regeneration.

Liu X, Gaihre B, Park S, Li L, Dashtdar B, Astudillo Potes MD, Terzic A, Elder BD, Lu L. Liu X, et al. Among authors: lu l. Bioact Mater. 2023 Apr 13;27:216-230. doi: 10.1016/j.bioactmat.2023.03.021. eCollection 2023 Sep. Bioact Mater. 2023. PMID: 37122896 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

163 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Results by year